| Linnig, Lukas (BRAIN 202010– CFO before Head of Financing, Controlling + Legal joined 201704) |
Chief Financial Officer (CFO) |
BRAIN (Group) |
Germany |
| Linscheid, Michael W. (Humboldt Univ Berlin 1009 Professor) |
n. a. |
Humboldt University Berlin |
Germany |
| Linseis, Brigitte (Bavaria (govt) 201402 Senior Investment Manager at Bayern Kapital) |
Investment Manager |
Bavaria (govt region) |
Germany |
| Linsinger, Thomas (EU (govt) 201605 JRC-IRMM Responsible CRM Distriubtion/Scientific Officer) |
n. a. |
EU (govt) |
Belgium |
| Linssen, Marcel (Wilex 201309 CBO at Heidelberg Pharma GmbH) |
Chief Business Officer (CBO) |
Heidelberg Pharma (Group) |
Germany |
| Linton, William A. (Bill) (Promega 1978– CEO + Founder and Eppendorf 201701– Supervisory Board Member) |
Chief Executive Officer (CEO) |
Promega (Group) |
United States (USA) |
| Linz, Fritjof (Sartorius 201903 Head of Separation at SSB) |
President/Director/Head Business Group/Unit/Division |
Sartorius (Group) |
Germany |
| Linzbach, Gerold (Symrase 200804 CEO) |
Chief Executive Officer (CEO) |
Symrise (Group) |
Germany |
| Lippold, Björn (Chemie.de 201403 Senior Editor) |
Editor / Publisher |
Lumitos (Group) |
Germany |
| Lippold, Marcus ([iito] Business Intelligence 2002–) |
Company Founder |
[iito] Business Intelligence |
Germany |
| Lipps, Ben (MagForce 201411 CEO) |
Chief Executive Officer (CEO) |
MagForce (Group) |
Germany |
| Lipscombe, Richard (Proteomics International 201201 Managing Director) |
Managing Director |
Proteomics International Pty Ltd. |
Australia |
| Litchman, Manuel (Mustang Bio 201704– CEO before Arvinas + Novartis Pharmaceuticals Corp) |
Chief Executive Officer (CEO) |
Mustang Bio Inc. (Nasdaq: MBIO) |
United States (USA) |
| Litow, Micah (Danaher 201405 Director Reserarch + Innovation Advanced Staining Instruments at Leica Biosystems) |
n. a. |
Danaher (Group) |
Germany |
| Little, Melvyn (Affimed 2000–201112 CSO + founder retired 12/11 before DKFZ) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Affimed (Group) |
Germany |
| Little, Stephen (Premaitha Health 201512 CEO before Qiagen + DxS) |
Chief Executive Officer (CEO) |
Premaitha Health (Group) |
United Kingdom (GB) |
| Little, Tod (Taconic 201309 CEO) |
Chief Executive Officer (CEO) |
Taconic (Group) |
United States (USA) |
| Litzka, Olivier (LCF Rothschild 2006–200911– Partner EdRIP before 3i Venture Healthcare) |
Partner (venture partner) |
Andera Partners (FR) |
France |
| Liu, Cheng (Eureka Therapeutics 201505 CEO) |
Chief Executive Officer (CEO) |
Eureka Therapeutics Inc. |
United States (USA) |
| Liu, Douglas (Qiagen 200507–201710c VP Global Operations before Bayer Healthcare RETIRED 2017) |
n. a. |
Qiagen (Group) |
Netherlands |
| Liu, Jack (OmicSoft Corp 201701 President + Co-Founder) |
President/Director/Head Business Group/Unit/Division |
Qiagen (Group) |
United States (USA) |
| Llewellyn, Chris (Schauenburg 201912 Asia Pacific Sales Manager at Markes 201406 Global Channel Manager) |
Sales Manager / Marketing Manager |
Schauenburg (Group) |
United Kingdom (GB) |
| Llewellyn-Davies, Peter (Apeiron 201807– CEO before CFO+CBO before Accellerate Partners + Medigene + Wilex) |
Chief Executive Officer (CEO) |
Apeiron (Group) |
Austria |
| Llobet, Manuel (Allergy Therapeutics 201709 CEO) |
Chief Executive Officer (CEO) |
Allergy Therapeutics (Group) |
United Kingdom (GB) |
| Lloyd-Harris, Genghis (Abingworth 201402 Partner) |
Partner (venture partner) |
Abingworth (Group) |
United Kingdom (GB) |
| Lo, Richard (Techcomp 201411 CEO) |
Chief Executive Officer (CEO) |
Techcomp (Group) |
China |
| Loa, Alexander (acCELLerate GmbH 201605 Managing Director) |
Managing Director |
Accellerate GmbH |
Germany |
| Lobacki, Joseph (Micromet 201112– COO before Genzyme SVP + General Manager before SangStat Medical + Cell Pathways) |
Chief Operating Officer (COO) |
Amgen (Group) |
United States (USA) |
| Lochter, André (atugen 2003– before Nordic Bioscience) |
n. a. |
Silence Therapeutics (Group) |
Germany |
| Locker, Susanne (LISAvienna 201310 Project Manager Marketing + PR) |
Sales Manager / Marketing Manager |
Austria (govt) |
Austria |
| Lockhoff, Oswald (Sidanis Pharma 201102– Managing Director + Founder before Consultant before Bayer) |
Managing Director |
Sidanis Pharma GmbH |
Germany |
| Loeb, Gary H. (Sangamo 201907– EVP + General Counsel before Achaogen + Amyris + Genentech) |
General Counsel / Chief Legal Officer (CLO) |
Sangamo (Group) |
United States (USA) |
| Loehr, Achim (CureVac 201710 Head Business Development) |
Business Development Manager / Strategy Manager |
CureVac (Group) |
Germany |
| Loescher, Peter (Siemens 200705– CEO before Merck & Co) |
Chief Executive Officer (CEO) |
Siemens (Group) |
Germany |
| Loew-Friedrich, Iris (UCB 201403 CMO before Schwarz Pharma) |
Chief Medical Officer (CMO) |
UCB (Group) |
Belgium |
| Lofton-Day, Catherine (Epigenomics 200607 VP Molecular Biology, Diagnostics) |
n. a. |
Epigenomics (Group) |
Germany |
| Lohfink, Martin (up to data 201003 Managing Director) |
Managing Director |
up to data professional services GmbH |
Germany |
| Lohmann, Charlotte (MorphoSys 201205– General Counsel before Wilex SVP Legal Affairs + Human Resources before KPMG) |
General Counsel / Chief Legal Officer (CLO) |
MorphoSys (Group) |
Germany |
| Lohmann, Christian (Peqlab Biotechnologie 200512) |
n. a. |
Avantor (Group) |
Germany |
| Lohmer, Stefan (Axxam 200807 CEO) |
Chief Executive Officer (CEO) |
Axxam S.p.A. |
Italy |
| Lohrisch, Hans-Joachim (Altana Pharma 200607 CEO) |
Chief Executive Officer (CEO) |
Takeda (Group) |
Germany |
| Lohrmann, Marc (Vesalius Biocapital 202001 Managing Partner at Vesalius Biocapital III) |
Managing Partner (investment firm) |
Vesalius Biocapital (Group) |
Luxembourg |
| Lohse, Axel (Germany (govt) 201611 Manager Biotech + Pharma at GTAI) |
Administrative Officer (personnel) |
Germany (govt) |
Germany |
| Loibner, Hans (Apeiron Biologics 200810–201807 CEO RETIRED 7/18 continues as senior advisor) |
Chief Executive Officer (CEO) |
Apeiron (Group) |
Austria |
| Loiret-Bernal, Cédric (GeneProt 200009 CEO) |
Chief Executive Officer (CEO) |
GeneProt Inc. |
Switzerland |
| Longchamp, Pascal (Evolva 201201–201712 CBO TO STEP DOWN unitl end 2017) |
Chief Business Officer (CBO) |
Evolva (Group) |
Switzerland |
| Looi, Liew Yew (Nycomed 201011 SVP North Asia) |
Regional manager |
Takeda (Group) |
Switzerland |
| Loose, Achim (Nordantec GmbH 200902 Managing Director) |
Managing Director |
Nordantec GmbH Norddeutsche Analytik und Messtechnik |
Germany |
| Lopata, Michael (Agilent 200809) |
n. a. |
Agilent (Group) |
Germany |
| Lopes-Fernandes, Philippe (Ipsen 202010– EVP + CBO based in US before Merck KGaA) |
Chief Business Officer (CBO) |
Ipsen (Group) |
France |
| Lopez Belda, Antonio (Biofrontera 201503– Marketing Manager at Biofrontera Spain before Allergan Pharmaceuticals) |
Sales Manager / Marketing Manager |
Biofrontera (Group) |
Spain (España) |
| Lopriore, Stefano (STMicroelectronics 200506) |
n. a. |
STMicroelectronics (Group) |
Switzerland |
| Lorenz, Fabian (MC Services 201504– Senior Consultant) |
Public Relations Manager / Investor Relations Manager |
MC Services AG |
Germany |
| Lorenz, Martin (Platomics 201908 Head of Marketing + Sales) |
Sales Manager / Marketing Manager |
Platomics GmbH |
Austria |
| Lorenz, Michael (Univ Bremen + Molzym) |
Managing Director |
Kompass (Group) |
Germany |
| Lorenz, Sarah (Univ München 202004 Director Business Development at German Entrepreneurship GmbH) |
Business Development Manager / Strategy Manager |
LMU Munich (Ludwig-Maximilians-Universität München, University of Munich) |
Germany |
| Los, Georgyi (Leica 200808 Lead Scientist Imaging Products) |
n. a. |
Danaher (Group) |
Germany |
| Loss, Christian (Neopharm 201502 Managing Director of Neovii Biotech GmbH) |
Managing Director |
Neopharm (IL) (Group) |
Germany |
| Lossau, Harald |
n. a. |
FRIZ Biochem GmbH |
Germany |
| Lottspeich, Friedrich (MPI 1993) |
n. a. |
Max Planck Society for the Advancement of Science |
Germany |
| Loumaye, Ernest (ObsEva 201211– CEO + Co-founder before PregLem SA CEO + founder + Ipsen + Serono) |
Chief Executive Officer (CEO) |
ObsEva (Group) |
Switzerland |
| Love, Douglas (Doug) (Annexon Biosciences 201812 CEO) |
Chief Executive Officer (CEO) |
Annexon Inc. (ANNX) |
United States (USA) |
| Loven, Jakob (Nextech Invest 201904 Partner) |
Partner (venture partner) |
Nextech (Group) |
Switzerland |
| Loveridge, Jason (4SC 201609– CEO) |
Chief Executive Officer (CEO) |
4SC (Group) |
Germany |
| Lowenstein, Inese (Danaher 201709– President at Sciex joined 8/16 before Merck KGaA) |
President/Director/Head Business Group/Unit/Division |
Danaher (Group) |
United States (USA) |
| Lowinger, Timothy B. (Mersana Therapeutics 201406 CSO) |
Chief Scientific Officer (CSO) / Chief Development Officer (CDO) |
Mersana Therapeutics Inc. (Nasdaq: MRSN) |
United States (USA) |
| Loy, André (Stratec 201107 Investor Relations) |
Public Relations Manager / Investor Relations Manager |
Stratec (Group) |
Germany |
| Lubenau, Heinz (Vaximm 201101 Managing Director Vaximm GmbH before BioGeneriX before Servier) |
Managing Director |
Vaximm (Group) |
Germany |
| Lubenow, Helge (Proteomedix 202001– CEO before Consultant before 1997–2015 at Qiagen) |
Chief Executive Officer (CEO) |
Proteomedix AG |
Switzerland |
| Lubert, Wolfgang (EnjoyVenture Management GmbH 201003 Managing Director [CEO]) |
Managing Director |
EnjoyVenture (Group) |
Germany |
| Lucas, Svetlana (Tizona Therapeutics 201510 VP Business Development) |
Business Development Manager / Strategy Manager |
Tizona Therapeutics Inc. |
|
| Luchinat, Claudio (Univ Florence 201706 Professor + Co-Founder of Magnetic Resonance Center (CERM)) |
Professor |
University of Florence |
Italy |
| Lucier, Gregory T. (NuVasive 201505– CEO before CEO of Life Technologies + Invitrogen 2003–2014) |
Chief Executive Officer (CEO) |
NuVasive (Group) |
United States (USA) |
| Lucke, Marc-Olivier (Atlantic Labs Manager GmbH 201909) |
n. a. |
Atlantic Labs Manager GmbH |
Germany |
| Ludwig, Matthias (Endress+Hauser 201705 Life Science Applications Specialist at Analytik Jena) |
n. a. |
Endress+Hauser (Group) |
Germany |
| Ludwig, Petra (Technologiepark Warnemünde 201103 Managing Director) |
Managing Director |
Technologiepark Warnemünde GmbH (TPW) |
Germany |
| Lues, Inge (Probiodrug 201410–201810 Chief Developm Offficer RETIRED 10/18 before Merck KGaA 1998–2007) |
Research & Development Manager |
Vivoryon (Group) |
Germany |
| Luider, Theo (Erasmus Univ 201206 Head of Laboratories of Neuro-Oncology at Dept of Neurology at EMC) |
Laboratory Manager (university / research institute) |
Erasmus University Rotterdam |
Netherlands |
| Luly, Jay R. (Enanta Pharmaceuticals 201202 CEO) |
Chief Executive Officer (CEO) |
Enanta Pharmaceutcials Inc. |
United States (USA) |
| Lun, Klaus (Tecan 201612– promoted to Head of Life Sciences joined 201306 before Molecular Devices + Leica Microsystems) |
President/Director/Head Business Group/Unit/Division |
Tecan (Group) |
Switzerland |
| Lundberg, Bill (Merus 202001– CEO formerly CRISPR Therapeutics + Alexion + Taligen) |
Chief Executive Officer (CEO) |
Merus (Group) |
Netherlands |
| Lundberg, Jan M. (Lilly 201003– EVP Science + Technology before AstraZeneca EVP Global Discovery Research) |
Research & Development Manager |
Eli Lilly (Group) |
United States (USA) |
| Lundemose, Anker (Mission Therapeutics 201501– CEO before Bionor Pharma + OSI Pharma + Prosidion + Novo Nordisk) |
Chief Executive Officer (CEO) |
Mission Therapeutics Ltd. |
United Kingdom (GB) |
| Luo, Jiali (Boehringer 201801 General Manager of Boehringer Ingelheim Biopharmaceuticals (China) Co Ltd) |
General Manager (management) |
Boehringer Ingelheim (Group) |
China |
| Luo, Peizhi (Peter) (Adagene 201904 CEO + Founder before Abmaxis) |
Chief Executive Officer (CEO) |
Adagene (Group) |
China |
| Luria, Xavier (AMP BIosimilars 201504 Scientific Board Member + former Head of Medicines Safety + Efficacy at EMA) |
Board member, non-executive |
AMP Biosimilars AG |
Germany |
| Luscombe, Caroline (Sanofi 201810– Head of Human Resources before LafargeHolcim + Syngenta + GE + Amersham) |
Human Resources Manager |
Sanofi (Group) [since May 2011] |
France |
| Lusser, Markus B. (Danaher 201507– President Leica Microsystems before VP Global Sales AB Sciex) |
Managing Director |
Danaher (Group) |
Germany |
| Luther, Rolf (Fuchs Petrolub 201409 Head of Advanced Development) |
Research & Development Manager |
Fuchs Petrolub (Group) |
Germany |
| Lutz, Michael (HepaRegenix 201910– Managing Director (CEO) before LifeCodexx + Clinical Data/Cogenics + Epidauros) |
Managing Director |
HepaRegenix GmbH |
Germany |
| Lutz, Phillipe (Telormedix 201005– CFO before Synosia Therapeutics CFO before Credit Suisse) |
Chief Financial Officer (CFO) |
Telormedix S.A. |
Switzerland |
| Lübbert, Hermann (Biofrontera 200311 CEO) |
Chief Executive Officer (CEO) |
Biofrontera (Group) |
Germany |
| Lübke, Julian (Cubuslab 201905 HeadProduct + Co-Founder) |
Product Manager (personnel) |
Labforward (Group) |
Germany |
| Lücke, Klaus (Gilupi GmbH 2006–201605 Managing Director + Founder LEFT 5/16) |
Managing Director |
Viroad (Group) |
Germany |
| Lüdke, Gerd (Curetis 201310 Director Bio-Assay Development) |
Research & Development Manager |
Curetis (Group) |
Germany |
| Lührs, Renke (Buse Heberer Fromm 201508 + DBI AG 201508 Supervisor Board Member) |
Attorney / Lawyer |
Buse Heberer Fromm Rechtsanwälte |
Germany |
| Lührs, Thorsten (SeNostic GmbH 201412– Managing Director + CO-Founder) |
Managing Director |
SeNostic GmbH |
Germany |
| Lüking, Angelika (Protagen 201009 Head R&D) |
Research & Development Manager |
Oncimmune (Group) |
Germany |
| Lynch, Carol (Novartis 201801 Global Head Biopharmaceuticals at Sandoz) |
President/Director/Head Business Group/Unit/Division |
Novartis (Group) |
Germany |
| Lynch, John (Waters 201404 VP Investor Relations) |
Public Relations Manager / Investor Relations Manager |
Waters (Group) |
United States (USA) |
![[LSG] Life-Sciences-Germany.com - The Life Sciences Web Portal for German-speaking Europe](/images/basics/lsg-life-sciences-germany-portal-logo-2019.png){kind=logo}
1 2 3 ... 38 39 40 ... 73 74 75 
![Picture [iito] Männer Ballett 650x80px](/banner/iito-business-intelligence-20200507-650-080-summer-banner-series-maenner-ballett.jpg)
![Picture [iito] No Content Marketing 650x80px](/banner/iito-business-intelligence-20200507-650-080-summer-banner-series-no-content-marketing.jpg)
![Picture [iito] LSE iitoLifeScience Life Sciences Mass Spec 120x120px](/banner/iito-business-intelligence-20111029-120-120-twitter-iitolifescience-germany-europe-mass-spec.jpg)
![Picture [LSUS] Life-Sciences-USA.com – The Business Web Portal 120x600px](/banner/iito-20181119-120-600-lsus-life-sciences-usa-com.jpg)
